Arcturus

ARCT NASDAQ
6.35
-0.59
-8.50%
已收盘, 16:00 06/14 EDT
开盘
6.88
昨收
6.94
最高
6.95
最低
6.21
成交量
3.87万
成交均量(3M)
4.44万
52周最高
10.00
52周最低
4.110
换手率
0.36%
市值
6,833.57万
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Arcturus ARCT股票价格,Arcturus股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Arcturus Therapeutics Ltd. is a ribonucleic acid (RNA) medicines company. The Company owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis and vaccines. The Company’s versatile RNA therapeutics platforms can be applied toward multiple types of RNA medicines, including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA and gene editing therapeutics. The Company's UNA technology can be used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes.
展开 >

最近浏览

名称
价格
涨跌幅